Campbell & CO Investment Adviser LLC purchased a new stake in shares of Masimo Corporation (NASDAQ:MASI) during the second quarter, according to its most recent filing with the SEC. The institutional investor purchased 2,223 shares of the medical equipment provider’s stock, valued at approximately $203,000.
A number of other large investors also recently bought and sold shares of MASI. JPMorgan Chase & Co. increased its stake in Masimo Corporation by 11.2% in the first quarter. JPMorgan Chase & Co. now owns 455,338 shares of the medical equipment provider’s stock valued at $42,466,000 after buying an additional 45,833 shares during the period. Geode Capital Management LLC increased its stake in Masimo Corporation by 36.9% in the first quarter. Geode Capital Management LLC now owns 645,254 shares of the medical equipment provider’s stock valued at $60,175,000 after buying an additional 173,931 shares during the period. Swiss National Bank increased its stake in Masimo Corporation by 0.9% in the first quarter. Swiss National Bank now owns 77,800 shares of the medical equipment provider’s stock valued at $7,256,000 after buying an additional 700 shares during the period. Norges Bank bought a new stake in Masimo Corporation during the fourth quarter valued at $26,532,000. Finally, NN Investment Partners Holdings N.V. bought a new stake in Masimo Corporation during the second quarter valued at $785,000. 84.39% of the stock is owned by hedge funds and other institutional investors.
Masimo Corporation (NASDAQ MASI) traded up 1.88% on Friday, reaching $83.58. 604,908 shares of the company’s stock were exchanged. Masimo Corporation has a 52-week low of $53.78 and a 52-week high of $104.71. The firm’s 50 day moving average price is $92.27 and its 200 day moving average price is $89.85. The company has a market cap of $4.34 billion, a PE ratio of 13.70 and a beta of 0.80.
Masimo Corporation (NASDAQ:MASI) last announced its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 EPS for the quarter, topping analysts’ consensus estimates of $0.71 by $0.12. Masimo Corporation had a net margin of 45.90% and a return on equity of 23.45%. The firm had revenue of $192.90 million during the quarter, compared to analyst estimates of $189.03 million. During the same period in the previous year, the business posted $0.57 earnings per share. The business’s revenue for the quarter was up 11.8% on a year-over-year basis. On average, analysts expect that Masimo Corporation will post $2.80 earnings per share for the current year.
WARNING: “Campbell & CO Investment Adviser LLC Acquires Shares of 2,223 Masimo Corporation (NASDAQ:MASI)” was first reported by BNB Daily and is the sole property of of BNB Daily. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.baseball-news-blog.com/2017/08/14/campbell-co-investment-adviser-llc-invests-203000-in-masimo-corporation-nasdaqmasi-updated.html.
MASI has been the subject of several research analyst reports. Zacks Investment Research downgraded shares of Masimo Corporation from a “strong-buy” rating to a “hold” rating in a research note on Thursday, May 11th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $108.00 price target (up from $105.00) on shares of Masimo Corporation in a research note on Thursday, August 3rd. BidaskClub downgraded shares of Masimo Corporation from a “buy” rating to a “hold” rating in a research note on Wednesday, July 5th. Roth Capital lifted their price target on shares of Masimo Corporation from $96.00 to $105.00 and gave the company a “buy” rating in a research note on Wednesday, July 19th. Finally, Wedbush reaffirmed an “outperform” rating and issued a $112.00 price target on shares of Masimo Corporation in a research note on Monday, May 22nd. One investment analyst has rated the stock with a sell rating, four have given a hold rating and three have given a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $94.00.
In other news, COO Anand Sampath sold 40,000 shares of Masimo Corporation stock in a transaction that occurred on Tuesday, July 11th. The shares were sold at an average price of $92.00, for a total value of $3,680,000.00. Following the completion of the sale, the chief operating officer now directly owns 20,000 shares in the company, valued at $1,840,000. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jon Coleman sold 25,000 shares of Masimo Corporation stock in a transaction that occurred on Thursday, July 20th. The stock was sold at an average price of $97.50, for a total transaction of $2,437,500.00. Following the completion of the sale, the insider now owns 32,201 shares of the company’s stock, valued at $3,139,597.50. The disclosure for this sale can be found here. Insiders sold 115,000 shares of company stock valued at $10,773,180 over the last quarter. Company insiders own 16.60% of the company’s stock.
About Masimo Corporation
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.